Related Experiment Video

Updated: Jun 28, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

[Venous thromboembolism in children]

Ruta Tuckuviene1, Søren Paaske Johnsen, Jon Helgestad

  • 1Børneafdelingen, Aalborg Sygehus, DK-9000 Aalborg. rt@rn.dk

Ugeskrift for Laeger
|November 4, 2008
PubMed

Insights

Pediatric venous thromboembolism (VTE) is rising, with newborns and teens most at risk. While treatment with low-molecular-weight heparin is safe, its effectiveness in children requires further study.

Area of Science:

  • Pediatric Hematology
  • Vascular Medicine
  • Clinical Thrombosis Research

Context:

  • Venous thromboembolism (VTE) is increasingly recognized in pediatric populations.
  • Newborns and adolescents represent high-risk demographics for thrombosis.
  • Common triggers include infection, central venous lines, and chemotherapy.

Purpose:

  • To review the current understanding of pediatric venous thromboembolism.
  • To discuss the role of thrombophilia screening in children.
  • To evaluate current treatment strategies for pediatric thrombosis.

Summary:

  • Pediatric VTE incidence is rising, particularly in neonates and teenagers.
  • Risk factors include infection, central venous catheters, and chemotherapy; thrombophilia's role is unclear.
  • Low-molecular-weight heparin is a safe treatment option, but efficacy needs further investigation.

Impact:

  • Highlights the growing concern of pediatric thrombosis.
  • Informs diagnostic guidelines for thrombophilia screening in children.
  • Suggests low-molecular-weight heparin as a safe, yet unproven, therapeutic option for pediatric VTE.

More Related Videos

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...